
3 science-backed ways to fall asleep almost instantly
A recent report in New Scientist has brought together three scientific methods, such as cognitive shuffling, cognitive behavioural therapy for insomnia, and sleep sanctuaries. These natural methods backed by science can help anyone fall asleep almost instantly.
One of the most common reasons that we struggle to fall asleep is restlessness or having worrying thoughts before bedtime. Cognitive shuffling is a technique that can help counter this. Developed by cognitive scientist Luc Beaudin, who is currently an adjunct professor at Simon Fraser University, it involves picking a random word that comes to the mind and trying to think of more words that start with the letters as part of the initial word. One is advised to simultaneously think of the words and even picture them in their head.
For instance, if you pick the word 'open', you need to think of words starting with the letter O and visualise them in your head at the same time. After O, think of words starting with P, and so on.
The technique has proven its effectiveness. A 2016 study by Simon Fraser University tested as many as 154 students who reported 'pre-sleep arousal' or heightened alertness before falling asleep. These students were asked to try the cognitive shuffling method, and the results showed that the students fell asleep faster.
Despite being initially developed for insomnia patients, aspects of CBT-I can also be used by everyone to fall asleep faster. At its core, CBT-I teaches people to repress their intrusive thoughts in order to prevent mental alertness and an increase in adrenaline levels, as these can prevent sleep. CBT-I also teaches calming techniques, like meditation, to prevent nervousness before sleeping.
The full CBT-I course may take up to eight weeks to complete. However, certain elements of the therapy, when relevant, can help people fall asleep sooner. A similar effect is seen with meditation. According to a 2021 study published in General Hospital Psychiatry, participants who used meditation apps showed improvement in their depression and anxiety symptoms which they exhibited earlier.
Sleep-restriction therapy is another aspect of CBT-I that can be effective. As counterintuitive as it sounds, this has proved its effectiveness. The theory is centred around attempting to get the number of hours spent in the bed as close to the actual hours of sleep as possible.
While this can sound complicated, it essentially entails making your room a 'sleep-friendly place'. This, at its most basic, can entail a cool, dark, and quiet environment. This can encourage secretion of melatonin from the brain's pineal glands, a hormone that encourages sleep.
Another popular piece of advice is to avoid screens soon before sleeping. The explanation for this is that the blue light from smartphones or other devices suppresses melatonin production. A May 2025 study published in the Frontiers in Psychiatry journal found that those who use screens in bed had 24 per cent lower chances of reporting insomnia symptoms, as compared to those using screens. As per this study, screen usage should stop 30 to 60 minutes before going to sleep.
It needs to be noted that a continued lack of sleep can trigger an array of health risks such as hypertension, diabetes, obesity, depression, heart attack, and stroke. It is crucial to sleep soundly and for the right amount of time. Furthermore, in case of insomnia, it is crucial to go to a specialist and begin a treatment programme as soon as possible.
(This article has been curated by Purv Ashar, who is an intern with The Indian Express)

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Time of India
3 days ago
- Time of India
IIT-Indore launches School of Innovation offering BDes programme
Indore: The Indian Institute of Technology, Indore (IIT-I), has launched the 'School of Innovation' offering a four-year full-time Bachelor of Design (BDes) programme, commencing in July for the new academic session. The programme encompasses foundational and advanced courses in design, innovation, and system engineering, focusing on value creation, while delivering comprehensive solutions to pressing social challenges in priority sectors. "The School of Innovation represents IIT Indore's strong commitment to shaping the future of design-led education and research in India. We believe that innovation emerges at the intersection of disciplines, and this school will provide a unique environment where creativity meets technology and human-centred design. Through this initiative, we aim to nurture responsible designers and innovators who will tackle the most urgent societal problems of our time," said IIT-I director Suhas Joshi. "We are excited to welcome the first batch of students and look forward to their contributions in building a more inclusive, sustainable, and innovative future for India and the world," Joshi said. The initiative has been taken under the National Initiative for Design Innovation (NIDI) scheme, introduced by the ministry of education to foster innovation, design, and creative problem-solving. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like 2025년 가장 여유 넘치는 농장 게임. 설치 없음 Taonga: 아일랜드 팜 플레이하기 Undo Admission will be through the national-level Undergraduate Common Entrance Examination for Design (UCEED), conducted annually by IIT Bombay, open to students from science, commerce, arts, and humanities backgrounds. Professor Avinash Sonawane, head of the School of Innovation at IIT-I said, "The idea is to focus on different sectors and benefit them by innovations and designing. Modern tools and technologies will be used and taught to students to address social problems in priority sectors." Students will undertake foundation courses in their first year, followed by specialisation options from the second year onwards in urban systems innovation, educational technologies, healthcare systems, or sustainable energy systems. Get the latest lifestyle updates on Times of India, along with Doctor's Day 2025 , messages and quotes!


The Hindu
4 days ago
- The Hindu
Blood and its components can be transported safely with drones by following guidelines: ICMR study
Blood and its components can be transported safely using drones by following standard guidelines, which can be particularly helpful in ensuring the availability of blood in emergencies across difficult terrains, a recently published study by Indian Council of Medical Research (ICMR) states. Titled 'Adopting drone technology for blood delivery: A feasibility study to evaluate its efficiency and sustainability', ICMR's lead study assesses the impact of drone-based delivery on blood components, comparing their delivery via conventional modes of transportation. The study aims to lay the foundation for successful and sustainable drone-based blood delivery programmes in India. Drone technology provides opportunities for improvement in the healthcare sector, primarily in remote environments and rural areas, by enabling just-in-time delivery of life-saving medical supplies, the study says. However, the transportation of blood and its components is complicated as they need to be stored at a specified temperature, or else their functionality is adversely affected, for example, the oxygen carrying ability of blood is greatly reduced. Moreover, the risk of bacterial contamination rises if it's exposed to aseptic conditions or a warm environment. Conversely, blood exposed to extreme lower temperatures may get haemolysed, which could lead to a fatal transfusion reaction. Maintaining cold chain integrity is essential for compliance and accreditation in the delivery of blood and its components. The study documents the challenges experienced by the team during the drone-based delivery while maintaining the biochemical parameters of blood components. 'During drone-based transportation, the temperature, integrity of blood cells, and other parameters were maintained, while slight changes in few parameters were observed via both [conventional and drone-based] transportation modes. In this study, the drone travelled around 36 kilometres in eight minutes, while the [road transport] van took around 55 minutes to cover the same distance,'' Sumit Aggarwal, Scientist and Programme Officer, I-Drone lead and in-charge, ICMR, said. Blood banks and transfusion services adhere to stringent national and international regulations, and quality standards that mandate strict temperature control throughout the blood supply chain, from collection to transfusion, Dr. Aggarwal said. 'Climatic conditions are crucial since drone transportation and blood biochemicals can be affected by environmental factors. With India's diverse and distinct topographical variations and geographical spread, the delivery of healthcare supplies faces multiple challenges,'' he added. Drone trials in other countries, including Italy and Rwanda, have indicated drones are a viable solution for blood transportation, and do not affect the integrity of blood and its components, in spite of occasional accelerations and decelerations en route, the study says. Obstacles for ground vehicles, including geographical distances, challenging topographical features such as mountains and rivers, poor or underdeveloped road systems, can be overcome with drones as a mode of transportation, another Southeast Asian study has suggested. 'Hence, the drone is a potential alternative to explore in tropical countries as a first response vehicle in emergencies. But more scientific evidence is required about the practicality, operational challenges and impact on the quality of blood after transportation via drone,'' the ICMR study states. Understanding the operational challenges for the transportation of blood bags via drones is a vital step, the study says.


Time of India
5 days ago
- Time of India
Brain scan reveals why Parkinson's drugs don't always work: Study
Washington: Simon Fraser University Researchers are using an advanced brain imaging method called MEG to understand why Parkinson's drug levodopa doesn't work equally well for everyone. By mapping patients' brain signals before and after taking the drug, they discovered that it sometimes activates the wrong brain regions, dampening its helpful effects. This breakthrough could pave the way for personalised treatment strategies, ensuring patients receive medications that target the right areas of their brain more effectively. The new study by the Simon Fraser University (SFU) researchers, published in the journal Movement Disorders, looks at why levodopa - the main drug used in dopamine replacement therapy - is sometimes less effective in patients. The drug is typically prescribed to help reduce the movement symptoms associated with the neurodegenerative disorder . While it is effective in improving symptoms for the vast majority of patients, not everyone experiences the same level of benefit. In order to find out why this is the case, an SFU collaboration with researchers in Sweden has used magnetoencephalography (MEG) technology to determine how the drug affects signals in the brain. "Parkinson's is the second most prevalent neurodegenerative disease worldwide and it is the most rapidly increasing, in terms of incidence," says Alex Wiesman, assistant professor in biomedical physiology and kinesiology at SFU. "Treating this disease, both in terms of helping people with their symptoms, but also trying to find ways to reverse the effects, is becoming more and more important. If clinicians can see how levodopa activates certain parts of the brain in a patient, it can help to inform a more personalised approach to treatment," added Wiesman. The study was a collaboration with researchers at Karolinska Institute in Sweden, who used MEG to collect data from 17 patients with Parkinson's disease - a relatively small sample size. Researchers mapped participants' brain signals before and after taking the drug, in order to see how and where the drug impacted brain activity. MEG is an advanced non-invasive technology that measures the magnetic fields produced by the brain's electrical signals. It can help clinicians and researchers to study brain disorders and diseases, including brain injuries, tumours, epilepsy, autism, mental illness and more. Using this rare brain imaging technology, Wiesman and team developed a new analysis that lets them "search" the brain for off-target drug effects. "With this new way of analysing brain imaging data, we can track in real time whether or not the drug is affecting the right brain regions and helping patients to manage their symptoms," says Wiesman. "What we found was that there are sometimes 'off-target' effects of the drug. In other words, we could see the drug activating brain regions we don't want to be activating, and that's getting in the way of the helpful effects. We found that those people who showed 'off target' effects are still being helped by the drug, but not to the same extent as others," said Wiesman. Parkinson's disease is a neurodegenerative disorder, meaning parts of the brain become progressively damaged over time. It affects predominately the dopamine-producing neurons in a specific area of the brain called the substantia nigra. People with Parkinson's disease may experience a range of movement-related symptoms, such as tremors, slow movement, stiffness and balance problems. Wiesman hopes that a better understanding of how levodopa affects an individual's brain signals could improve how drugs are prescribed to treat Parkinson's. This new type of brain imaging analysis is not only for studying Parkinson's disease; any medications that affect brain signaling can be studied using the method developed by Wiesman and colleagues. (ANI)